Integration of single-cell and bulk transcriptomics for deciphering prognostic value and immunotherapeutic features of floatptosis-mediated cell death in lung adenocarcinoma.
9 affiliations
- 1Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical University, Bengbu, China.
- 2Department of Medical Imaging, Bengbu Medical University, Bengbu, China.
- 3Anhui Key Laboratory of Digital Medicine and Intelligent Health, Bengbu Medical University, Bengbu, China.
- 4Department of Clinical Medicine, Bengbu Medical University, Bengbu, China.
- 5Department of Psychiatry, Bengbu Medical University, Bengbu, China.
- 6Department of Stomatology, Bengbu Medical University, Bengbu, China.
- 7School of Life Sciences, Bengbu Medical University, Bengbu, China.
- 8Department of Radiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
- 9Department of Thoracic Surgery, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Abstract
Recent research has uncovered an unprecedented cell death pathway induced by outer membrane vesicles derived from Bergeyella cardium variant (BCV). This process promotes the pathological fusion of lysosome-related organelles via the SLC9A9 protein, leading to the formation of large vacuoles and ultimately inducing a terminal vacuolar cell death termed floatptosis. However, the role of floatptosis-related genes (FRGs) in lung adenocarcinoma (LUAD) remains largely unexplored. In this study, we constructed a LUAD prognostic model based on FRGs to predict patient prognosis and further explored the characteristics of lysosome fusion-associated terminal vacuolar cell death (floatptosis) at the single-cell level. In this research, we systematically analyzed data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases to explore SLC9A9, an FRG. A total of 50 genes were screened out via co-expression analysis. The AddModuleScore algorithm was utilized to calculate floatptosis scores across different cell clusters, which were then divided into high- and low-score subgroups. The differentially expressed genes (DEGs) derived from the two subgroups were enrolled in weighted gene co-expression network analysis (WGCNA) to screen key gene modules closely linked to LUAD. Single-cell and bulk transcriptome analyses combined with WGCNA identified 74 FRGs. Genes contained in these modules were further analyzed by differential expression analysis and univariate Cox regression. Based on FRGs, consensus clustering was applied to identify molecular subtypes, and least absolute shrinkage and selection operator (LASSO) regression was utilized to establish a prognostic signature. Combined with multiple immune infiltration algorithms, tumor mutational burden (TMB) analysis and cell communication analysis, we explored the correlation between floatptosis and the tumor microenvironment (TME), so as to provide novel therapeutic strategies for LUAD. A total of 74 FRGs were identified through single-cell and bulk transcriptome analyses, among which 11 exhibited differential expression between tumor and normal tissues. Of these, 7 genes were found to be significantly correlated with overall survival (OS). Pseudotime trajectory analysis of macrophages revealed that risk-associated genes were predominantly upregulated at later stages, whereas protective genes tended to decrease over time. Five of these genes were ultimately selected to establish a prognostic signature based on FRGs. Patients stratified into the low-FRGs group showed a markedly better prognosis than those in the high-FRGs group. Intercellular communication analysis further demonstrated that macrophages with elevated FRGs expression displayed enhanced activity in the C-C motif chemokine ligand (CCL), activated leukocyte cell adhesion molecule (ALCAM), and colony-stimulating factor (CSF) signaling pathways. The prognostic model constructed based on FRGs allows for reliable survival prediction in LUAD patients and offers valuable insights into the immune microenvironment of LUAD. Notably, macrophages with high floatptosis scores can enhance the invasive and migratory capacities of tumor cells, making them promising novel therapeutic targets for LUAD.
Related
- Single-cell and spatial transcriptomics in intrahepatic cholangiocarcinoma: spatial immune ecosystems, metabolic remodeling, and immunotherapeutic implications
- A multi-omics study integrating single-cell transcriptomics, spatial transcriptomics, and mendelian randomization unveil the implication of TRDMT1 expression in T cells on the immunotherapeutic response and prognosis in breast cancer.
- Prognostic and immunotherapeutic implications of histamine-related biomarkers in lung adenocarcinoma
- Spatial Transcriptomics in Chronic Rhinosinusitis: Deciphering Tissue Architecture, Immune Niches, and Precision Therapeutics
- A single-cell transcriptomics-based prognostic model identifies TM4SF1 as a key promoter of malignant progression in lung adenocarcinoma
BibTeX
@article{wang2026integration,
title = {{Integration of single-cell and bulk transcriptomics for deciphering prognostic value and immunotherapeutic features of floatptosis-mediated cell death in lung adenocarcinoma.}},
author = {Hanyang Wang and Yilun Shi and Qili Xue and Yu Jiao and Junnan Qian and Ziyue Liu and Zongyu Xie and Lei Zhang and Wenrui Wang},
journal = {Translational cancer research},
year = {2026},
month = sep,
doi = {10.21037/tcr-2026-1097},
url = {https://europepmc.org/article/MED/42997895},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Integration of single-cell and bulk transcriptomics for deciphering prognostic value and immunotherapeutic features of floatptosis-mediated cell death in lung adenocarcinoma.
AU - Hanyang Wang
AU - Yilun Shi
AU - Qili Xue
AU - Yu Jiao
AU - Junnan Qian
AU - Ziyue Liu
AU - Zongyu Xie
AU - Lei Zhang
AU - Wenrui Wang
PY - 2026
DA - 2026/09/28
JO - Translational cancer research
DO - 10.21037/tcr-2026-1097
UR - https://europepmc.org/article/MED/42997895
AB - Recent research has uncovered an unprecedented cell death pathway induced by outer membrane vesicles derived from Bergeyella cardium variant (BCV). This process promotes the pathological fusion of lysosome-related organelles via the SLC9A9 protein, leading to the formation of large vacuoles and ultimately inducing a terminal vacuolar cell death termed floatptosis. However, the role of floatptosis-related genes (FRGs) in lung adenocarcinoma (LUAD) remains largely unexplored. In this study, we constructed a LUAD prognostic model based on FRGs to predict patient prognosis and further explored the characteristics of lysosome fusion-associated terminal vacuolar cell death (floatptosis) at the single-cell level. In this research, we systematically analyzed data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases to explore SLC9A9, an FRG. A total of 50 genes were screened out via co-expression analysis. The AddModuleScore algorithm was utilized to calculate floatptosis scores across different cell clusters, which were then divided into high- and low-score subgroups. The differentially expressed genes (DEGs) derived from the two subgroups were enrolled in weighted gene co-expression network analysis (WGCNA) to screen key gene modules closely linked to LUAD. Single-cell and bulk transcriptome analyses combined with WGCNA identified 74 FRGs. Genes contained in these modules were further analyzed by differential expression analysis and univariate Cox regression. Based on FRGs, consensus clustering was applied to identify molecular subtypes, and least absolute shrinkage and selection operator (LASSO) regression was utilized to establish a prognostic signature. Combined with multiple immune infiltration algorithms, tumor mutational burden (TMB) analysis and cell communication analysis, we explored the correlation between floatptosis and the tumor microenvironment (TME), so as to provide novel therapeutic strategies for LUAD. A total of 74 FRGs were identified through single-cell and bulk transcriptome analyses, among which 11 exhibited differential expression between tumor and normal tissues. Of these, 7 genes were found to be significantly correlated with overall survival (OS). Pseudotime trajectory analysis of macrophages revealed that risk-associated genes were predominantly upregulated at later stages, whereas protective genes tended to decrease over time. Five of these genes were ultimately selected to establish a prognostic signature based on FRGs. Patients stratified into the low-FRGs group showed a markedly better prognosis than those in the high-FRGs group. Intercellular communication analysis further demonstrated that macrophages with elevated FRGs expression displayed enhanced activity in the C-C motif chemokine ligand (CCL), activated leukocyte cell adhesion molecule (ALCAM), and colony-stimulating factor (CSF) signaling pathways. The prognostic model constructed based on FRGs allows for reliable survival prediction in LUAD patients and offers valuable insights into the immune microenvironment of LUAD. Notably, macrophages with high floatptosis scores can enhance the invasive and migratory capacities of tumor cells, making them promising novel therapeutic targets for LUAD.
SN - 2218-676X
SN - 2219-6803
ER -